P Taxel

Summary

Affiliation: University of Connecticut Health Center
Country: USA

Publications

  1. ncbi The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men
    P Taxel
    Division of Endocrinology and Metabolism, Center on Aging, University of Connecticut Health Center, Farmington, Connecticut 06030 1317, USA
    J Clin Endocrinol Metab 86:2869-74. 2001
  2. ncbi The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism, Farmington, Conneticut 06030 5456, USA
    Aging Male 11:71-5. 2008
  3. ncbi Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study
    P Taxel
    Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 5456, USA
    Osteoporos Int 19:193-9. 2008
  4. ncbi Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
    Pamela Taxel
    Department of Medicine, Radiation Oncology, Surgery and General Clinical Research Center, University of Connecticut Health Center, Farmington, CT 06030 5456, USA
    BJU Int 106:1473-6. 2010
  5. ncbi Changes in urinary excretion of helical peptide during therapy for osteoporosis in older adults
    Pamela Taxel
    Division of Endocrinology and Metabolism, University of Connecticut Health Center, Farmington, CT, USA
    Clin Chem 50:747-50. 2004
  6. ncbi The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism and Center on Aging, University of Connecticut Health Center, Farmington, Connecticut 06030, USA
    J Am Geriatr Soc 52:269-73. 2004
  7. ncbi The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 1317, USA
    J Clin Endocrinol Metab 87:4907-13. 2002
  8. ncbi Osteoporosis in older men and women
    Anne M Kenny
    University of Connecticut Center on Aging, University of Connecticut Health Center, Farmington, Farmington, CT, USA
    Conn Med 67:481-6. 2003
  9. ncbi Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation
    Nitya G Chakraborty
    Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 1315, USA
    Cancer Immunol Immunother 52:497-505. 2003
  10. ncbi The use of estrogen therapy in men
    Yasmine Sayed
    University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030-1317, USA
    Curr Opin Pharmacol 3:650-4. 2003

Research Grants

  1. Estrogen regulation of osteoclastogenesis in older men
    Pamela Taxel; Fiscal Year: 2003

Collaborators

Detail Information

Publications14

  1. ncbi The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men
    P Taxel
    Division of Endocrinology and Metabolism, Center on Aging, University of Connecticut Health Center, Farmington, Connecticut 06030 1317, USA
    J Clin Endocrinol Metab 86:2869-74. 2001
    ....
  2. ncbi The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism, Farmington, Conneticut 06030 5456, USA
    Aging Male 11:71-5. 2008
    ..While the current report is very preliminary in a small group of subjects, further studies are needed to determine the long-term effects of E(2) in this population of hypogonadal men...
  3. ncbi Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study
    P Taxel
    Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 5456, USA
    Osteoporos Int 19:193-9. 2008
    ..E(2) treatment inhibited the ability of hematopoietic cells to form OCLs in response to RANKL, and decreased RANKL production. These changes are likely involved in the ability of E(2) to influence the development of osteoporosis...
  4. ncbi Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
    Pamela Taxel
    Department of Medicine, Radiation Oncology, Surgery and General Clinical Research Center, University of Connecticut Health Center, Farmington, CT 06030 5456, USA
    BJU Int 106:1473-6. 2010
    ....
  5. ncbi Changes in urinary excretion of helical peptide during therapy for osteoporosis in older adults
    Pamela Taxel
    Division of Endocrinology and Metabolism, University of Connecticut Health Center, Farmington, CT, USA
    Clin Chem 50:747-50. 2004
  6. ncbi The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism and Center on Aging, University of Connecticut Health Center, Farmington, Connecticut 06030, USA
    J Am Geriatr Soc 52:269-73. 2004
    ....
  7. ncbi The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer
    Pamela Taxel
    Division of Endocrinology and Metabolism, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 1317, USA
    J Clin Endocrinol Metab 87:4907-13. 2002
    ..We conclude that E(2) inhibits bone resorption in hypogonadal men through a direct skeletal effect that is independent of PTH. Low dose estrogen may be an option for the prevention and/or treatment of bone loss in this population...
  8. ncbi Osteoporosis in older men and women
    Anne M Kenny
    University of Connecticut Center on Aging, University of Connecticut Health Center, Farmington, Farmington, CT, USA
    Conn Med 67:481-6. 2003
    ..Recommendations for treatment and prevention of osteoporosis based on bone mineral density score published by the World Health Organization and the National Osteoporosis Foundation are outlined...
  9. ncbi Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation
    Nitya G Chakraborty
    Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 1315, USA
    Cancer Immunol Immunother 52:497-505. 2003
    ....
  10. ncbi The use of estrogen therapy in men
    Yasmine Sayed
    University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030-1317, USA
    Curr Opin Pharmacol 3:650-4. 2003
    ..In some areas, such as the bone and cardiovascular systems, insights are beginning to be gained. Nevertheless, the clinical use of estrogen in men is limited...
  11. ncbi The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer
    R S Boxer
    Center on Aging, University of Connecticut Health Center, Farmington 06030-5215, USA
    Aging Male 8:207-12. 2005
    ..Lifestyle changes or medical interventions to minimize the effects of androgen deprivation therapy for PCa deserve investigation...
  12. ncbi Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk
    Cherian Joseph
    UConn Center on Aging, University of Connecticut Health Center, MC-5215, 263 Farmington Ave, Farmington, CT 06030-5215, United States
    Mol Aspects Med 26:181-201. 2005
    ....
  13. ncbi Cancer therapy and osteoporosis: approach to evaluation and management
    G J van Londen
    Department of Medicine, Divisions of Geriatrics and Hematology Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Semin Oncol 35:643-51. 2008
    ..This article reviews the mechanisms of bone metabolism and the principles of management of bone health in the older population with a history of cancer...
  14. ncbi A review of the association between osteoporosis and alveolar ridge augmentation
    Ozgur Erdogan
    Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cukurova University, Adana, Turkey
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:738.e1-13. 2007
    ..Relationship between low bone density/osteoporosis and bone graft success is still not clear. The purpose of this article is to review and summarize the literature regarding the success of alveolar bone augmentation in osteoporosis...

Research Grants1

  1. Estrogen regulation of osteoclastogenesis in older men
    Pamela Taxel; Fiscal Year: 2003
    ..abstract_text> ..